1 / 63

Paediatric Rheumatology

Paediatric Rheumatology. Phil Riley Consultant Paediatric Rheumatologist Teaching. Introduction. Musculoskeletal pain common in childhood Wide range of diagnoses -benign to malignant JIA- early recognition and appropriate treatment prevents damage JIA- Multidisciplinary team.

thane
Download Presentation

Paediatric Rheumatology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Paediatric Rheumatology Phil Riley Consultant Paediatric Rheumatologist Teaching

  2. Introduction • Musculoskeletal pain common in childhood • Wide range of diagnoses -benign to malignant • JIA- early recognition and appropriate treatment prevents damage • JIA- Multidisciplinary team

  3. Differential Diagnosis • Inflammatory • Mechanical • Psychological

  4. Differential Diagnosis-Inflammatory • Reactive • Infection • Inflammatory disease • Systemic disease • Malignancy • Irritable hip

  5. Differential Diagnosis-Mechanical • Trauma-accidental and NAI • Hypermobility • Osteochondritides • Degenerative disorders • Haematological • Metabolic • Tumours- benign and malignant

  6. Differential-Psychogenic • Fibromyalgia • Functional illness • Reflex Sympathetic Dystrophy

  7. Juvenile Idiopathic Arthritis • Unknown aetiology • Genetic predisposition • incidence 1 per 10,000 • prevalence 1 per 1,000

  8. Disease Course • 50% still active after 25 years • X-ray Joint damage by 2.6 years • Increased mortality • Increased morbidity-Physical • -Growth • -Psychological • -Social

  9. Classification of Juvenile Arthritis • <16 years • >6 weeks arthritis • Subtypes classified for first 6 months

  10. Subtypes • Oligoarthritis 1-4 -persistent -extended • Polyarthritis (RF negative) >=5 • Polyarthritis (RF positive) >=5 • systemic

  11. Investigations-JIA • ANA- Antinuclear antibody • Inflammatory markers- CRP,ESR • FBC- Anaemia of chronic disease • x-ray -loss of joint space, erosions and carpal bone overcrowding • MRI- synovitis (gadolinium enhanced)

  12. Uveitis • Chronic anterior uveitis • Often Asymptomatic • Young,female, oligoarthritis, positive ANA (30%) • Polyarthritis (5%) • systemic(rare) • Slit lamp 3-6 monthly for 7 years

  13. Subtypes • Systemic Arthritis -Rash -temp over 2 weeks -with/without arthritis -with/without serositis -hepatosplenomegaly, lymphadenopathy

  14. JIA • systemic rash

  15. Systemic JIA • Quotidian fever

  16. Systemic JIA • Macrophage Activation Syndrome(MAS) -Bleeding, purpura, bruising -Nodes,liver,spleen -FBC,ESR -PT,APTT, FDP - Fibrinogen,clotting factors • Bone Marrow • IV steroids,Cyclosporin

  17. Subtypes • Enthesitis-related arthritis -HLA B27 • Psoriatic Arthritis • Other

  18. Treatment Options • NSAIDs • Steroids • Joint injections • Methotrexate • Sulphasalazine • Ciclosporin • TNF drugs • Autologous stem cell transplantation

  19. Questions • Oligoarthritis • ANA pos • normal slightly raised ESR,CRP • NSAIDS • Joint injection • Ophthalmology referral • Rehab/MDT

  20. Questions • Polyarthritis • ANA positive or negative • Rh factor positive or negative • very raised ESR,CRP • Steroids • Methotrexate • Eyes • Rehab/MDT

  21. Questions • Systemic • Rash • Quotidian fever • NSAIDS • Steroids • Methotrexate • Macrophage Activation Syndrome

  22. Treatment Concepts • Early • Monitoring • Multidisciplinary

  23. Treatment continued • Physiotherapy • restore function • improve muscle strength • splints/serial casts • Occupational therapy • Psychology

  24. Spotter • Butterfly Rash

  25. Spotter • Buttterfly

  26. Spotter • Raynaud’s phenomenon

  27. SLE- Diagnostic/ WHO classification criteria(4 of 11) • Malar rash(butterfly) • Discoid lupus rash • Photosensitivity • Oral/nasal mucosal ulceration • Non-erosive arthritis • nephritis -proteinuria/cellular casts

  28. SLE-Diagnostic/WHO classification(4 of 11) • Encephalopathy-seizures/psychosis • Pleuritis/pericarditis • Haematological -lymphopaemia -thrombocytopaenia • positive immunoserology -anti ds-DNA • ANA positive

  29. SLE- clinical features • Constitutional - fever/malaise/weight loss • Cutaneous • rash/photosensitivity/alopecia/mouth ulcers • Musculoskeletal • poly-arthritis/arthralgia • tenosynovitis • myopathy • avascular necrosis

  30. SLE-Clinical features • Vascular • lupus crisis/Raynaud’s/livedo • Cardiac • pericarditis/myocarditis/endocarditis • Pulmonary • pleuritis/pneumonitis/haemorrhage

  31. SLE-lab features • FBC- low platelets - low lymphocytes • Inflammatory markers- high ESR, normal CRP • ANA- very high ie >1:2560 • DsDNA- high • C3,C4- low

  32. Spotter • Neonatal lupus

  33. Spotter • Neonatal Lupus

  34. Neonatal lupus • Maternal autoantibody transmission • Cong heart block (Ro/La) - 50% • Cutaneous neonatal lupus - 37% • Hepatic/GI tract - 8% • Haematologic -6% • Neurologic and pulmonary -1%

  35. Spotter • Heliotrope Rash

  36. Spotter • Gottrons papules

  37. Spotter • Calcinosis

  38. Spotter • Capillaroscopy • Abnormal “bushy” • Thickening and dropout

  39. Definition of Juvenile Dermatomyositis(JDM) • limb-girdle and anterior neck flexor weakness • Muscle biopsy • Muscle enzyme increase • EMG • Dermatological features

  40. JDM - clinical features • Proximal weakness • Vasculopathy • Heliotrope facial rash • Gottrons papules • Raised CK/LDH/AST/ALT • MR scan/muscle biopsy • Multi-organ occasionally

  41. JDM - treatment • Steroids • pulse iv • oral tapering • Methotrexate • Cyclosporin/Immunoglobulin/Cyclophosphamide/Anti TNF • Physio/Rehab

  42. Spotter • en coup de sabre

  43. Spotter • Sclerodactly

  44. Scleroderma in children • Systemic sclerosis • limited cutaneous/CREST • diffuse • Localised • linear scleroderma (en coup de sabre,morphoea)

  45. Questions

  46. Q1

  47. Q1

  48. Q2

  49. Q3

  50. Q4

More Related